Clinical Trial Update: Effectiveness and Safety of Biphasic Insulin Aspart 70/30 in Subjects With Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the effectiveness and safety of Biphasic Insulin Aspart 70/30 in adults with Type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Biphasic Insulin Aspart 70/30 (insulin aspart 70/30)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED